Why India's Second Wave Has Sparked Global Concerns?
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
In mid-March, 2021, the world wanted to believe that the worst of Covid-19 was already behind. In India too, the focus had largely shifted from containment to vaccinations. Immunisation drives were picking up in almost every country. And the world was looking up to India's production capacity for a steady supply, specially to the poorer countries.

India had given out millions of doses as aids to neighbours and friendly countries, shipped out in commercial contracts or to the UN's Covax program. By mid-March, India had exported over twice the number of doses it had administered at home. Modi government's Vaccine Maitri initiative seemed well on track. But then the story changed.

The daily infection rate, that was on a steady decline, took a reverse turn, almost with a vengeance. The government came under pressure over vaccine exports. Some opposition parties started questioning the policy, and demanded that exports be curtailed till the entire population is immunised. Union heath minister Harsh Vardhan made a statement in Parliament that vaccines are not being exported at the expense of Indians.

All major exports of the AstraZeneca vaccine, being manufactured by Pune's Serum Institute, were put on hold. The ripples were felt worldwide, as over 180 counties were to receive the drug through WHO's Covax vaccine sharing, and India was a major supplier. Only last week, the European Union asked India to allow it to buy 10 million doses of the AstraZeneca vaccine from Serum Institute to offset supply shortfall from European plants.

Britain too is pressuring for the doses it had ordered from Serum. The world's dependence on India for the vaccine can be gauged from the fact that a total of 84 countries have so far received India-made vaccines, either through grant, commercial purchase or via WHO's Covax program.

Dr. T●●●●z H●●●●●●i and 6 others like this3 shares